DA
UTHR icon

Denali Advisors’s United Therapeutics UTHR Stock Holding History

Denali Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$759K Sell
1,401
-101
-7% -$56.9K 0.08% 218
2026
Q1 		$891K Sell
1,502
-200
-12% -$99.6K 0.1% 192
2025
Q4 		$829K Sell
1,702
-201
-11% -$93.6K 0.09% 204
2025
Q3 		$798K Buy
1,903
+703
+59% +$236K 0.09% 184
2025
Q2 		$345K Sell
1,200
-303
-20% -$90.6K 0.04% 267
2025
Q1 		$463K Buy
1,503
+100
+7% +$34.3K 0.05% 239
2024
Q4 		$495K Buy
+1,403
New +$516K 0.05% 236
2021
Q3 		– Sell
-200
Closed -$36K – 325
2021
Q2 		$36K Buy
200
+100
+100% +$19K 0.01% 188
2021
Q1 		$17K Sell
100
-3,400
-97% -$567K 0.01% 293
2020
Q4 		$531K Sell
3,500
-800
-19% -$105K 0.09% 200
2020
Q3 		$434K Sell
4,300
-2,400
-36% -$263K 0.09% 211
2020
Q2 		$811K Buy
+6,700
New +$754K 0.16% 161
2019
Q4 		– Sell
-9,600
Closed -$766K – 354
2019
Q3 		$766K Sell
9,600
-76,900
-89% -$6.19M 0.11% 168
2019
Q2 		$6.75M Buy
86,500
+20,900
+32% +$1.95M 1.01% 41
2019
Q1 		$7.7M Sell
65,600
-27,400
-29% -$3.19M 1.23% 35
2018
Q4 		$10.1M Buy
+93,000
New +$10.8M 1.69% 26

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Denali Advisors's UTHR Position: Q2 2026 in Review

Denali Advisors reduced its United Therapeutics (UTHR) stake by 6.7% in Q2 2026, selling an estimated $56.9K and leaving 1,401 shares worth $759K. The position accounts for 0.08% of the portfolio, ranked #218.

Denali Advisors first reported a position in UTHR in Q4 2018 and has held it in 16 quarters since. The position peaked at $10.1M in Q4 2018. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Denali Advisors held 1,401 shares of United Therapeutics worth $759K as of Q2 2026.
  • Denali Advisors sold 101 United Therapeutics shares in Q2 2026, an estimated $56.9K.
  • United Therapeutics made up 0.08% of Denali Advisors's portfolio in Q2 2026, its #218 holding.
  • Denali Advisors first reported a position in United Therapeutics in Q4 2018 and has held it in 16 quarters since.
  • Denali Advisors's United Therapeutics position peaked at $10.1M in Q4 2018.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Denali Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.